Triple-Agonist Drug Retatrutide Delivers Record Weight Loss in Landmark Trial
Eli Lilly's retatrutide helped patients lose up to 85 pounds in a Phase 3 trial, rivaling bariatric surgery. The triple-agonist drug may redefine obesity treatm
Health | Science
Browse all Health | Science articles on Dayfeedz.com, updated daily with the latest news and analysis.